Active — Not RecruitingNot Applicable

miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction

Thailand160 participantsStarted 2000-08-26

Plain-language summary

The goal of this observational study is to compare miRNA and FGF21 in pregnancy with and without GDM (Gestational Diabetes) The main question it aims to answer that miRNA and FGF21 are different between two groups. Participants will be retrieved blood sample during first trimester and undergone 100 gm OGTT (oral glucose challenge test) during 24-28 weeks of gestation.

Who can participate

Age range45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * singleton pregnant women who attend at our clinic in first trimester Exclusion Criteria: * known underlying disease such as chronic hypertension, pregestational diabetes, SLE * normal structural fetal anatomical screening * incomplete obstetric data

What they're measuring

miRNA profile

Timeframe: within 1 month after blood drawn

Trial details

NCT IDNCT05632055

SponsorChiang Mai University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-11-21

View on ClinicalTrials.gov More Gestational Diabetes trials